These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21611979)

  • 1. A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study.
    Rosas HD; Reuter M; Doros G; Lee SY; Triggs T; Malarick K; Fischl B; Salat DH; Hersch SM
    Mov Disord; 2011 Aug; 26(9):1691-7. PubMed ID: 21611979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.
    Harris GJ; Codori AM; Lewis RF; Schmidt E; Bedi A; Brandt J
    Brain; 1999 Sep; 122 ( Pt 9)():1667-78. PubMed ID: 10468506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.
    Ruocco HH; Lopes-Cendes I; Li LM; Santos-Silva M; Cendes F
    Braz J Med Biol Res; 2006 Aug; 39(8):1129-36. PubMed ID: 16906288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, CAG repeat length, and clinical progression in Huntington's disease.
    Rosenblatt A; Kumar BV; Mo A; Welsh CS; Margolis RL; Ross CA
    Mov Disord; 2012 Feb; 27(2):272-6. PubMed ID: 22173986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
    Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
    Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease presenting as posterior cortical atrophy.
    Caixeta L
    Arq Neuropsiquiatr; 2011; 69(2B):407-8. PubMed ID: 21625777
    [No Abstract]   [Full Text] [Related]  

  • 10. The distribution of structural neuropathology in pre-clinical Huntington's disease.
    Thieben MJ; Duggins AJ; Good CD; Gomes L; Mahant N; Richards F; McCusker E; Frackowiak RS
    Brain; 2002 Aug; 125(Pt 8):1815-28. PubMed ID: 12135972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study.
    Hobbs NZ; Henley SM; Ridgway GR; Wild EJ; Barker RA; Scahill RI; Barnes J; Fox NC; Tabrizi SJ
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):756-63. PubMed ID: 19955112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
    Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
    J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
    Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
    Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional subcortical shape analysis in premanifest Huntington's disease.
    Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
    Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease.
    Johnson EB; Ziegler G; Penny W; Rees G; Tabrizi SJ; Scahill RI; Gregory S
    Biol Psychiatry; 2021 Apr; 89(8):807-816. PubMed ID: 33500176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAG repeat number governs the development rate of pathology in Huntington's disease.
    Penney JB; Vonsattel JP; MacDonald ME; Gusella JF; Myers RH
    Ann Neurol; 1997 May; 41(5):689-92. PubMed ID: 9153534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.
    Squitieri F; Cannella M; Simonelli M; Sassone J; Martino T; Venditti E; Ciammola A; Colonnese C; Frati L; Ciarmiello A
    CNS Neurosci Ther; 2009; 15(1):1-11. PubMed ID: 19228174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset Huntington's disease with 40-42 CAG expansion.
    Capiluppi E; Romano L; Rebora P; Nanetti L; Castaldo A; Gellera C; Mariotti C; Macerollo A; Cislaghi MG
    Neurol Sci; 2020 Apr; 41(4):869-876. PubMed ID: 31820322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ; Wood NI; Morton AJ
    J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.